e-learning
resources
London 2016
Sunday, 04.09.2016
What's new in biomarker analysis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased circulating fibrocytes in asthmatic patients with severe OSA
Tsai-Yu Wang (Taipei, Taiwan), Tsai-Yu Wang, Yu-Lun Lo, Chun-Hua Wang, Han-Pin Kuo
Source:
International Congress 2016 – What's new in biomarker analysis?
Session:
What's new in biomarker analysis?
Session type:
Thematic Poster
Number:
901
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tsai-Yu Wang (Taipei, Taiwan), Tsai-Yu Wang, Yu-Lun Lo, Chun-Hua Wang, Han-Pin Kuo. Increased circulating fibrocytes in asthmatic patients with severe OSA. Eur Respir J 2016; 48: Suppl. 60, 901
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The impact of CPAP on circulating IGF-1 in patients with OSAS
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Is there a relationship between OSAS severity and Nesfatin-1?
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016
The concentration and expression of L-selectin in normoglycemic obstructive sleep apnea patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
OSA complication score as novel reference to assess systemic inflammation in sleep apnoea
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015
NKT cells in systemic inflammation in the obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Comparison of peri-pharyngeal muscle recruitment during upper airway obstruction in patients with OSA and healthy subjects during wakefulness and sleep
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016
Association between 25-hydroxyvitamin D and interleukin 17 levels in severe obstructive sleep apnea syndrome
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Upper airway stimulation in OSA patients increases airway size in a dose-response manner
Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Year: 2013
Investigation of frequency of OSAS in patients with pulmonary hypertension by polysomnography
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Prevalence of overlap syndrome and its correlation with severity of obstructive sleep apnea syndrome
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015
Alternate overlap syndrome: Association of asthma with obstructive sleep apnea
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Airway inflammation and cold airway hyperresponsiveness in bronchial asthma patients with obstructive sleep apnea hypopnea syndrome
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014
Predictors of increased daytime sleepiness in patients with COPD
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Pharyngeal and systemic inflammation in obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015
Relationship between echocardiographic assessment and plasma endothelin-1 levels in obese patients with or without obstructive sleep apnea
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept